25,741
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Clinical study in genital herpes: natural Gene-Eden-VIR/Novirin versus acyclovir, valacyclovir, and famciclovir

, &
Pages 2713-2722 | Published online: 29 Aug 2016

References

  • JohnstonCCoreyLCurrent concepts for genital herpes simplex virus infection: diagnostics and pathogenesis of genital tract sheddingClin Microbiol Rev201629114916126561565
  • GuptaRWarrenTWaldAGenital herpesLancet200737096052127213718156035
  • CoreyLAdamsHGBrownZAHolmesKKGenital herpes simplex virus infections: clinical manifestations, course, and complicationsAnn Intern Med19839869589726344712
  • Lebrun-VignesBBouzamondoADupuyAGuillaumeJCLechatPChosidowOA meta-analysis to assess the efficacy of oral antiviral treatment to prevent genital herpes outbreaksJ Am Acad Dermatol200757223824617416440
  • KukhanovaMKKorovinaANKochetkovSNHuman herpes simplex virus: life cycle and development of inhibitorsBiochemistry (Mosc)201479131635165225749169
  • MattisonHRReichmanRCBenedettiJDouble-blind, placebo-controlled trial comparing long-term suppressive with short-term oral acyclovir therapy for management of recurrent genital herpesAm J Med1988852A20253044086
  • ReichmanRCBadgerGJMertzGJTreatment of recurrent genital herpes simplex infections with oral acyclovirJAMA198425116210321076368877
  • TyringSWaldAZadeikisNDhaddaSTakenouchiKRorigRASP2151 for the treatment of genital herpes: a randomized, double-blind, placebo-and valacyclovir-controlled, dose-finding studyJ Infect Dis201220571100111022351940
  • AokiFYTyringSDiaz-MitomaFGrossGGaoJHamedKSingle-day, patient-initiated famciclovir therapy for recurrent genital herpes: a randomized, double-blind, placebo-controlled trialClin Infect Dis200642181316323085
  • CoreyLWaldAPatelROnce-daily valacyclovir to reduce the risk of transmission of genital herpesN Engl J Med20043501112014702423
  • CernikCGallinaKBrodellRTThe treatment of herpes simplex infections: an evidence-based reviewArch Intern Med200816811113718541820
  • ReitanoMTyringSLangWValaciclovir for the suppression of recurrent genital herpes simplex virus infection: a large-scale dose range-finding study. International Valaciclovir HSV Study GroupJ Infect Dis199817836036109728526
  • PolanskyHJavaherian A. 3-Econsystems: microRNAs, receptors, and latent viruses: some insights biology can gain from economic theoryFront Microbiol2016736927047480
  • PolanskyHJavaherianACommentary: the unliganded glucocorticoid receptor positively regulates the tumor suppressor gene BRCA1 through GABP betaFront Cell Infect Microbiol201556626442220
  • PolanskyHMicrocompetition with Foreign DNA and the Origin of Chronic DiseaseNew YorkCBCD Publishing2003
  • PolanskyHItzkovitzEGene-Eden-VIR is antiviral: results of a post marketing clinical studyPharmacol Pharm201346A18
  • PolanskyHItzkovitzEGene-Eden-VIR decreased physical and mental fatigue in a post marketing clinical study that followed FDA guidelines; results support microcompetition theoryPharmacol Pharm201453280290
  • DouglasJMCritchlowCBenedettiJA double-blind study of oral acyclovir for suppression of recurrences of genital herpes simplex virus infectionN Engl J Med198431024155115566328298
  • MertzGJLovelessMOLevinMJOral famciclovir for suppression of recurrent genital herpes simplex virus infection in women. A multicenter, double-blind, placebo-controlled trial. Collaborative Famciclovir Genital Herpes Research GroupArch Intern Med199715733433499040303
  • PatelRBodsworthNJWoolleyPValaciclovir for the suppression of recurrent genital HSV infection: a placebo controlled study of once daily therapy. International Valaciclovir HSV Study GroupGenitourin Med19977321051099215091
  • YavuzBBCankurtaranMHalilMDagliNKirkpanturARenal dysfunction after oral acyclovir treatment in a geriatric woman: a case reportScand J Infect Dis200537861161316138435
  • BeckerBNFallPHallCRapidly progressive acute renal failure due to acyclovir: case report and review of the literatureAm J Kidney Dis19932246116158213806
  • BerryLVenkatesanPAciclovir-induced neurotoxicity: utility of CSF and serum CMMG levels in diagnosisJ Clin Virol201461460861025440915
  • Le CleachLTrinquartLDoGOral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patientsCochrane Database Syst Rev20148CD00903625086573
  • LamNNWeirMAYaoZRisk of acute kidney injury from oral acyclovir: a population-based studyAm J Kidney Dis201361572372923312723
  • LaconiSMadedduMAPompeiRAutophagy activation and antiviral activity by a licorice triterpenePhytother Res201428121890189224919871
  • WangLYangRYuanBLiuYLiuCThe antiviral and antimicrobial activities of licorice, a widely-used Chinese herbActa Pharm Sin B20155431031526579460
  • SabouriGMMohammadiASafiallahySFaradmalJAziziMAhmadvandZThe effect of aqueous extract of glycyrrhiza glaba on herpes simplex virus 1Jundishapur J Microbiol201477e1161625368801
  • HungPYHoBCLeeSYHouttuynia cordata targets the beginning stage of herpes simplex virus infectionPLoS One2015102e011547525643242
  • OriharaYHamamotoHKasugaHShimadaTKawaguchiYSekimizuKA silkworm baculovirus model for assessing the therapeutic effects of antiviral compounds: characterization and application to the isolation of antivirals from traditional medicinesJ Gen Virol200889Pt 118819418089742
  • ColpittsCCSchangLMA small molecule inhibits virion attachment to heparin sulfate- or sialic acid-containing glycansJ Virol201488147806781724789779
  • LeytonLHottMAcunaFNutraceutical activators of AMPK/Sirt1 axis inhibit viral production and protect neurons from neurodegenerative events triggered during HSV-1 infectionVirus Res2015205637226031763
  • SartoriGJardimNSMarcondes SariMHAntiviral action of diphenyl diselenide on herpes simplex virus 2 infection in female BALB/c miceJ Cell Biochem201611771638164826639776
  • US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER)Guidance for industry, E 10 choice of control group and related issues in clinical trials2001 Available from: http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm073139.pdfAccessed August 16, 2016
  • CalvertMKyteDDuffyHPatient-reported outcome (PRO) assessment in clinical trials: a systematic review of guidance for trial protocol writersPLoS One2014910e11021625333995
  • VodickaEKimKDevineEBGnanasakthyAScogginsJFPatrickDLInclusion of patient-reported outcome measures in registered clinical trials: evidence from ClinicalTrials.gov (2007–1013)Contemp Clin Trials2015431925896116
  • WillkeRJBurkeLBEricksonPMeasuring treatment impact: a review of patient-reported outcomes and other efficacy endpoints in approved product labelsControl Clin Trials200425653555215588741